The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

Abstract

The safety of blood transfusion is still threatened by contamination of blood products with a variety of pathogens such as viruses, bacteria and parasites. A novel pathogen reduction process for platelets and plasma products, the Mirasol PRT system, has been developed and is under clinical evaluation for its efficacy and safety. The Mirasol PRT process is based on riboflavin photochemistry. This manuscript reviews current progress and future trends.

020406020072008200920102011201220132014201520162017
Citations per Year

304 Citations

Semantic Scholar estimates that this publication has 304 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Goodrich2006TheMP, title={The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.}, author={Raymond P. Goodrich and Richard A Edrich and Junzhi Li and Jerard Seghatchian}, journal={Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis}, year={2006}, volume={35 1}, pages={5-17} }